NCT05814991

Brief Summary

It is very important to decrease the bleeding during bimaxillary osteotomy in order to increase the visibility of the surgical site. Our primary goal is to investigate the predictive value of pre- and perioperative factors, including controlled hypotension, on visibility of surgical site during bimaxillary osteotomy.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
May 2023Jun 2026

First Submitted

Initial submission to the registry

April 3, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

May 29, 2023

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Expected
Last Updated

May 31, 2023

Status Verified

May 1, 2023

Enrollment Period

2.6 years

First QC Date

April 3, 2023

Last Update Submit

May 30, 2023

Conditions

Keywords

nitroglycerinthe quality of visualization of the operating fieldNear-infrared Spectroscopy (NIRS)cerebral oximetryregional cerebral oxygen saturation (rSO2)Le Fort; Icontrolled hypotension anesthesia

Outcome Measures

Primary Outcomes (1)

  • Visibility of surgical site

    Surgical site will be rated according to Modena Bleeding Score (MBS) by the same surgeon in terms of bleeding during osteotomy. The MBS goes from Grade 1 - no bleeding to Grade 5 - bleeding that prevents every surgical procedure except those dedicated to bleeding control.

    during osteotomy, up to 90 minutes

Secondary Outcomes (7)

  • Proportion of patients with cerebral desaturation

    during osteotomy, up to 90 minutes

  • changes in the values of mean arterial pressure

    during the whole surgery (from start to finish - the timing stated in the surgery protocol)

  • Changes in neuron-specific enolase (NSE) concentration

    3 time-points during the surgery - immediately after anesthesia induction, at the time of controlled hypotension (5 minutes after induction of controlled hypotension, i.e. nitroglycerin i.v. administration), immediately after extubation

  • Intraoperative blood loss

    during the whole surgery (from start to finish - the timing stated in the surgery protocol)

  • Cognitive status change

    within 3 days before operation, 2 days after surgery, 1 month after surgery

  • +2 more secondary outcomes

Study Arms (1)

Patients undergoing bimaxillary osteotomy under general anesthesia

Drug: Nitroglycerin solutionDevice: monitoring of cerebral oxygen saturation

Interventions

Controlled hypotension will be induced (intravenous administration of nitroglycerin 2-10 µg/kg/min) 15 minutes prior to the start of mucosal detachment, and will be sustained for the osteotomy stage.

Patients undergoing bimaxillary osteotomy under general anesthesia

NIRS-based monitoring of rSO2 has unique advantages: directly or indirectly detecting physiological changes and metabolic processes, it is easy to realize, and involves simple procedures.

Also known as: NIRS
Patients undergoing bimaxillary osteotomy under general anesthesia

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

patients undergoing bimaxillary osteotomy under general anesthesia

You may qualify if:

  • Patients refered for bimaxillary osteotomy under general anesthesia with endotracheal intubation;
  • Anesthesia risk classes (ASA) I and II;
  • Written statement of informed consent.

You may not qualify if:

  • Hypertension as a symptom of hypertensive heart disease or endocrine dysfunction;
  • Patients receiving antihypertensive drugs;
  • Patients receiving anticoagulant therapy;
  • Ischemic heart disease;
  • Cerebrovascular insufficiency;
  • Severe hypovolemia;
  • Anemia;
  • BMI 30 kg/m2 and higher;
  • Connective tissue disorders;
  • Pregnancy;
  • Participation in other clinical studies;
  • Recent history of substance abuse (recreational drugs, alcohol);
  • Allergies to drugs used in the study;
  • Anxiety requiring psychiatrist supervision and pharmacological therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pirogov National Medical and Surgical Center

Moscow, 105203, Russia

Location

Related Publications (16)

  • Pineiro-Aguilar A, Somoza-Martin M, Gandara-Rey JM, Garcia-Garcia A. Blood loss in orthognathic surgery: a systematic review. J Oral Maxillofac Surg. 2011 Mar;69(3):885-92. doi: 10.1016/j.joms.2010.07.019. Epub 2010 Dec 31.

    PMID: 21195531BACKGROUND
  • Sugahara K, Koyama Y, Koyachi M, Watanabe A, Kasahara K, Takano M, Katakura A. A clinico-statistical study of factors associated with intraoperative bleeding in orthognathic surgery. Maxillofac Plast Reconstr Surg. 2022 Feb 25;44(1):7. doi: 10.1186/s40902-022-00336-8.

    PMID: 35212834BACKGROUND
  • Salma RG, Al-Shammari FM, Al-Garni BA, Al-Qarzaee MA. Operative time, blood loss, hemoglobin drop, blood transfusion, and hospital stay in orthognathic surgery. Oral Maxillofac Surg. 2017 Jun;21(2):259-266. doi: 10.1007/s10006-017-0626-1. Epub 2017 May 2.

    PMID: 28466191BACKGROUND
  • Ha TN, van Renen RG, Ludbrook GL, Valentine R, Ou J, Wormald PJ. The relationship between hypotension, cerebral flow, and the surgical field during endoscopic sinus surgery. Laryngoscope. 2014 Oct;124(10):2224-30. doi: 10.1002/lary.24664. Epub 2014 Apr 22.

    PMID: 24604576BACKGROUND
  • Ferri J, Druelle C, Schlund M, Bricout N, Nicot R. Complications in orthognathic surgery: A retrospective study of 5025 cases. Int Orthod. 2019 Dec;17(4):789-798. doi: 10.1016/j.ortho.2019.08.016. Epub 2019 Sep 5.

    PMID: 31495753BACKGROUND
  • Degoute CS. Controlled hypotension: a guide to drug choice. Drugs. 2007;67(7):1053-76. doi: 10.2165/00003495-200767070-00007.

    PMID: 17488147BACKGROUND
  • Ettinger KS, Yildirim Y, Weingarten TN, Van Ess JM, Viozzi CF, Arce K. Hypotensive Anesthesia Is Associated With Shortened Length of Hospital Stay Following Orthognathic Surgery. J Oral Maxillofac Surg. 2016 Jan;74(1):130-8. doi: 10.1016/j.joms.2015.05.025. Epub 2015 May 28.

    PMID: 26047710BACKGROUND
  • Lin S, McKenna SJ, Yao CF, Chen YR, Chen C. Effects of Hypotensive Anesthesia on Reducing Intraoperative Blood Loss, Duration of Operation, and Quality of Surgical Field During Orthognathic Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Oral Maxillofac Surg. 2017 Jan;75(1):73-86. doi: 10.1016/j.joms.2016.07.012. Epub 2016 Jul 25.

    PMID: 27542543BACKGROUND
  • Varol A, Basa S, Ozturk S. The role of controlled hypotension upon transfusion requirement during maxillary downfracture in double-jaw surgery. J Craniomaxillofac Surg. 2010 Jul;38(5):345-9. doi: 10.1016/j.jcms.2009.10.012. Epub 2009 Nov 12.

    PMID: 19913434BACKGROUND
  • Rodrigo C. Induced hypotension during anesthesia with special reference to orthognathic surgery. Anesth Prog. 1995;42(2):41-58.

    PMID: 8934953BACKGROUND
  • Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018 Oct;121(4):706-721. doi: 10.1016/j.bja.2018.04.036. Epub 2018 Jun 20.

    PMID: 30236233BACKGROUND
  • Mathis MR, Naik BI, Freundlich RE, Shanks AM, Heung M, Kim M, Burns ML, Colquhoun DA, Rangrass G, Janda A, Engoren MC, Saager L, Tremper KK, Kheterpal S, Aziz MF, Coffman T, Durieux ME, Levy WJ, Schonberger RB, Soto R, Wilczak J, Berman MF, Berris J, Biggs DA, Coles P, Craft RM, Cummings KC, Ellis TA 2nd, Fleishut PM, Helsten DL, Jameson LC, van Klei WA, Kooij F, LaGorio J, Lins S, Miller SA, Molina S, Nair B, Paganelli WC, Peterson W, Tom S, Wanderer JP, Wedeven C; Multicenter Perioperative Outcomes Group Investigators. Preoperative Risk and the Association between Hypotension and Postoperative Acute Kidney Injury. Anesthesiology. 2020 Mar;132(3):461-475. doi: 10.1097/ALN.0000000000003063.

    PMID: 31794513BACKGROUND
  • Gregory A, Stapelfeldt WH, Khanna AK, Smischney NJ, Boero IJ, Chen Q, Stevens M, Shaw AD. Intraoperative Hypotension Is Associated With Adverse Clinical Outcomes After Noncardiac Surgery. Anesth Analg. 2021 Jun 1;132(6):1654-1665. doi: 10.1213/ANE.0000000000005250.

    PMID: 33177322BACKGROUND
  • Farah GJ, de Moraes M, Filho LI, Pavan AJ, Camarini ET, Previdelli IT, Coelho L. Induced hypotension in orthognathic surgery: a comparative study of 2 pharmacological protocols. J Oral Maxillofac Surg. 2008 Nov;66(11):2261-9. doi: 10.1016/j.joms.2008.06.045.

    PMID: 18940490BACKGROUND
  • Rhee SH, An JS, Seo KS, Karm MH. Predictors of Red Blood Cell Transfusion in Bimaxillary Orthognathic Surgery: A Retrospective Study. Int J Med Sci. 2021 Jan 29;18(6):1432-1441. doi: 10.7150/ijms.55567. eCollection 2021.

    PMID: 33628100BACKGROUND
  • Thiele RH, Shaw AD, Bartels K, Brown CH 4th, Grocott H, Heringlake M, Gan TJ, Miller TE, McEvoy MD; Perioperative Quality Initiative (POQI) 6 Workgroup. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Cerebral Near-Infrared Spectroscopy. Anesth Analg. 2020 Nov;131(5):1444-1455. doi: 10.1213/ANE.0000000000005081.

    PMID: 33079868BACKGROUND

MeSH Terms

Conditions

MalocclusionMaxillofacial InjuriesHemorrhage

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesFacial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesWounds and InjuriesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2023

First Posted

April 18, 2023

Study Start

May 29, 2023

Primary Completion

January 15, 2026

Study Completion (Estimated)

June 15, 2026

Last Updated

May 31, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share
Shared Documents
CSR
Time Frame
6 months after completion of the study
Access Criteria
upon the request

Locations